Skip to main content
. 2015 Apr 2;112(10):1703–1708. doi: 10.1038/bjc.2015.116

Figure 2.

Figure 2

MED12 mutations in phyllodes tumours and fibroadenomas of the breast. (A) MED12 mutations in phyllodes tumours. (B) Microdissection-based analysis of MED12 mutations. Epithelial and stromal components of phyllodes tumours or fibroadenomas were separately microdissected and analysed for the presence of MED12 mutations. The arrowheads indicate missense mutations. The underline indicates deletions.